The Molecular Basis of Cancer E-Book, 3rd Edition
|(With Adobe DRM, readable with Adobe Digital Editions for PCs and Macs, and on most mobile devices except Kindle)|
Successfully fighting cancer starts with understanding how it begins. This thoroughly revised 3rd Edition explores the scientific basis for our current understanding of malignant transformation and the pathogenesis and treatment of cancer. A team of leading experts thoroughly explain the molecular biologic principles that underlie the diagnostic tests and therapeutic interventions now being used in clinical trials and practice. Incorporating cutting-edge advances and the newest research, the book provides thorough descriptions of everything from molecular abnormalities in common cancers to new approaches for cancer therapy. A new full-color format expedites reference, and now as an Expert Consult title, it enables you to conveniently search the entire text online, download all of the book's images for your personal use, and review periodic updates.
New to This Edition
- Features numerous descriptions of the latest clinical strategies-helping you to understand and take advantage of today's state-of-the-art biotechnology advances.
- Features sweeping updates throughout, including molecular targets for the development of anti-cancer drugs, gene therapy, and vaccines...keeping you on the cutting edge of your specialty.
- Offers a new, more user-friendly full-color format so the information that you need is easier to find.
- Presents abundant figures-all redrawn in full color-illustrating major concepts for easier comprehension.
By John Mendelsohn, MD, President and Professor of Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX; Peter M. Howley, MD, Professor and Chairman, Department of Pathology, Harvard Medical School, Boston, MA; Mark A. Israel, MD, Director, Norris Cotton Cancer Center; Professor of Pediatrics and Genetics, Dartmouth Medical School, Hanover, NH; Joe W. Gray, PhD, Director, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA and Craig B. Thompson, MD, Director, Abramson Cancer Center; Professor of Medicine, University of Pennsylvania, Philadelphia, PA